Colour enhancement

From PsychonautWiki
(Redirected from Property:Colour enhancement)
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
1P-LSD
DOI
Methallylescaline
DOC
2C-E
LSZ
Βk-2C-B
25D-NBOMe
THJ-2201
LSD
25B-NBOH
MiPT
Phenethylamine (compound)
Experience:1mg 25c-NBOMe - Experiment in my room
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
2C-T-21
THJ-018
Selective serotonin reuptake inhibitor
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
DiPT
6-APB
Experience:250mg DXM - DXM Itch and Trip Report
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
2C-D
Omberacetam
2C-C
Experience:800 seeds LSA - My First Trip Ever
6-APDB
MDMA
Psilocybin mushrooms
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
Experience:25mg 3-MeO-PCP - Enhanced film experience
4-AcO-DET
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
Experience:4-AcO-DMT + 200mg Pill
4-HO-EPT
25I-NBOMe
Allylescaline
AL-LAD
4-AcO-DiPT
Experience:2 tabs DOB - My DOB Nightmare
Experience:4.5g - The Grand Introduction to Beauty and Fear
25C-NBOH
Aniracetam
3C-E
Experience:1050 µg 1cP-LSD - The matrix
Phenylpiracetam
Experience:4x 200ug tabs - You do not need to understand
MDA
25B-NBOMe
MDEA
Experience:~150mg MDA(oral) - a case of mistaken identity
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
TMA-6
Experience:BK-2C-B - Various experiences
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
Bufotenin
LSM-775
Experience:25mg Deschloroketamine - My first time orally dosing DCK
Piracetam
DOM
Mescaline
Chameleon.jpgChameleon by Anonymous.
ΑMT
Paradise island by Xanny.jpgParadise island by Subsentience
JWH-073
4-AcO-MET
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
LSA
Memantine
2C-B
5-MeO-DALT
4-HO-DiPT
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
MPT
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
Amanita muscaria
MET
EPT
25I-NBOH
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
Oxiracetam
4-FA
DPT
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
5-MeO-DiBF
Ayahuasca
MDAI
1P-ETH-LAD
Chur City in Switzerland.jpgChur, Switzerland by Naps284
JWH-018
25N-NBOMe
Experience:300µg LSD - Togetherness and the Silent Dusk
GABAergic hallucinogens
Bromo-DragonFLY
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
PRO-LAD
Experience:3-MeO-PCP - Extreme psychosis
Proscaline
4-HO-MiPT
4-HO-DET
2C-B-FLY
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
Experience:3g mimosa / 3g syrian rue - Connecting with my body
5-Hydroxytryptophan
Pregabalin
Tree.jpgJapanese Garden by Anonymous
DET
2C-H
3-MeO-PCE
MiPLA
25C-NBOMe
Psilocin
2C-P
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
4-HO-DPT
4-AcO-DMT
1B-LSD
DMT
ALD-52
4-HO-MPT
Pramiracetam
Experience:1000 Morning Glory seeds - Rediscovering the Self
PARGY-LAD
3-MMC
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
4-HO-MET
5-MeO-MiPT
ETH-LAD
2C-I
Escaline
4-AcO-MiPT
DOB
Experience:337mg DMT fumarate - A Day With DMT
Enhancement of colour rose.jpgRose by Chelsea Morgan
5-MeO-DiPT
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
Coluracetam
2C-T-2
Experience:40mg - Brothermind and the Forest's Hand
5F-PB-22
TMA-2
Experience:120mg - Garden of The Gods
Efavirenz
2C-T-7
Experience:4-HO-MiPT / A care free psychedelic getaway
Ibogaine

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.